Person: Dr Henry Mantsch

Dr Henry Mantsch

Dr Henry Mantsch has been appointed senior advisor at the Office of the National Science Advisor with a focus on international affairs. Mantsch comes to the NSA from the Canadian Embassy in Berlin where he was S&T counsellor for the past five years. His previous career with the National Research Council spanned 34 years and…

Dr Michael Owen

Dr Michael Owen has been appointed VP research and graduate studies at the Ontario College of Art and Design. Owen comes to the college from Brock Univ where he was associate VP research and international development and a professor in the faculty of education. Prior to that he was Brock’s director of research services –…

Dr Claire Bombardier

Dr Claire Bombardier has been selected as the first holder of the Pfizer Chair in Rheumatology at the Univ of Toronto. Bombardier is the director of the U of T’s division of rheumatology research in the department of medicine. The $2-million chair received $1.5 million in funding from Pfizer Canada.

Carol Stephenson

Carol Stephenson has been appointed dean of the Richard Ivey School of Business at the Univ of Western Ontario for a second five-year term. Stephenson’s first term was highlighted by an increasing emphasis on research and interdisciplinary initiatives allowing students to study business in conjunction

Robert Webb

Robert Webb has been appointed head of international S&T marketing for Defence R&D Canada (DRDC), on loan from the Department of Foreign Affairs and International Trade (DFAIT). Prior to joining DRDC, Webb was DFAIT’s S&T counsellor in Washington. He has been replaced by Lisette Ramcharan, a DFAIT foreign service officer with expertise in environmental policy.…

Dr Henry Mantsch

Dr Henry Mantsch has been appointed DFAIT’s S&T counsellor in Berlin .Mantsch comes to DFAIT from the National Research Council’s Institute for Biodiagnostics (IBD) where he was principal research officer and head of the spectroscopy section. Mantsch is a celebrated researcher and was co-founder of the IBD along with Dr Ian Smith, capping a career…

Dr Jinzi Jason

Dr Jinzi Jason has been appointed VP research of PhageTech Inc, a Montreal-based developer of antibiotic drugs based on proprietary phage genomics (bacterial viruses). Jason has considerable expertise in small molecule drugs discovery, with previous experience at Immunex, Novartis and Aventis. He holds an MD from Nanjing Univ’s school of medicine and a PhD in…